ArticleNature communications2025
In situ coordinated HTL strategy for high-performance and scalable perovskite solar cells.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Molecular coordination achieves uniform kesterite absorber film for efficient solar modules.Nature materials · 2026Article
- Self-Assembled Monolayers in Inverted Perovskite Solar Cells: A Rising Star with Challenges.Nano-micro letters · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Achieving uniform and stable hole transport layers (HTL) is crucial for large-area perovskite solar cells (PSCs). However, current self-assembled monolayer (SAM)-based HTL suffer from weak interfacial adhesion, poor film uniformity, and limited stability, constraining their scalability. Our study proposes an integrated HTL strategy with in situ SAM anchoring during NiO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.